Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06355115

Prophylactic Antibiotics Duration Towards Healing and Risk of Infection in Permanent Pacemaker (PPM) Installation (PACE-PRO)

Comparison Effect Between a Single Dose Prophylaxis Antibiotics Given One Day and Three Days Towards Healing and Risk of Infection in Permanent Pacemaker (PPM) Installation: a Preliminary Study

Sponsor: Saiful Anwar Hospital

Conditions Pacemaker Complication

Interventions Cefazolin 1000 MG Injection

Updated 3 times since 2024 Last updated: Apr 6, 2024 Started: Sep 1, 2023 Primary completion: Sep 1, 2024 Completion: Sep 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06355115, this PHASE2 trial focuses on Pacemaker Complication and remains actively recruiting participants. Sponsored by Saiful Anwar Hospital, it has been updated 3 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
May 2024 — Jul 2024 [monthly]

Recruiting PHASE2

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Saiful Anwar Hospital
University of Brawijaya

Data source: University of Brawijaya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Malang, Indonesia